BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30802150)

  • 1. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
    Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
    FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).
    Ye S; Liu Y; Fuller AM; Katti R; Ciotti GE; Chor S; Alam MZ; Devalaraja S; Lorent K; Weber K; Haldar M; Pack MA; Eisinger-Mathason TSK
    Mol Cancer Res; 2020 Apr; 18(4):560-573. PubMed ID: 31988250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer.
    Kang HG; Kim WJ; Kang HG; Chun KH; Kim SJ
    Mol Cancer Res; 2020 Mar; 18(3):403-413. PubMed ID: 31822520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of MTA1 protein overexpression-linked invasion: MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and function.
    Sankaran D; Pakala SB; Nair VS; Sirigiri DN; Cyanam D; Ha NH; Li DQ; Santhoshkumar TR; Pillai MR; Kumar R
    J Biol Chem; 2012 Feb; 287(8):5483-91. PubMed ID: 22203674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer.
    Wang MQ; Chen YR; Xu HW; Zhan JR; Suo DQ; Wang JJ; Ma YZ; Guan XY; Li Y; Zhu SL
    Cancer Sci; 2023 Apr; 114(4):1365-1377. PubMed ID: 36519789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
    Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
    Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced transmembrane protein 2 promotes epithelial-mesenchymal transition by activating transforming growth factor-β1/small mother against decapentaplegic 2 signaling in gastric cancer.
    Liu Y; Zhou M; Wu J; Wen Z; Fang Y; Lin L; Luo M; Sun L; Liao W
    Mol Biol Rep; 2022 Feb; 49(2):997-1006. PubMed ID: 34855108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers.
    Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
    Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
    [No Abstract]   [Full Text] [Related]  

  • 12. Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer.
    Zhang Y; Zhang Y; Geng L; Yi H; Huo W; Talmon G; Kim YC; Wang SM; Wang J
    J Biol Chem; 2016 Aug; 291(33):17405-16. PubMed ID: 27330076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.
    Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL
    Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
    Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
    Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
    Choi YJ; Baek GY; Park HR; Jo SK; Jung U
    PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells.
    Yang D; Ma Y; Zhao P; Ma J; He C
    Exp Cell Res; 2021 Nov; 408(2):112860. PubMed ID: 34624323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells.
    Lu H; Feng Y; Hu Y; Guo Y; Liu Y; Mao Q; Xue W
    J Cell Mol Med; 2020 Jan; 24(1):98-113. PubMed ID: 31691494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.